Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
These Cat Reactions To Owners Calling Them Through Security Cameras Are Absolutely Hilarious
Kentucky Nurse Saves Drunk Raccoon With CPR After Dumpster Mishap
Firefighters And Public Works Team Crawl Quarter Mile To Rescue Blind And Deaf Dog
Shoulder Labrum Tear Symptoms And The Causes Behind Them
The Mechanical Nurse At Guy’s Hospital Is Equal Parts Creepy And Brilliant
'Everyone Gets A Kick Out Of It': Baby Born At McDonald’s Parking Lot Has Perfect Nickname
Epic ‘Bohemian Rhapsody’ Flashmob Takes Over the Streets of Paris
Texas Cheerleaders Perform Emotional 9/11 Tribute That Brings Crowd To Tears
FDNY Honors Bride Whose Father Died On 9/11 With Touching Wedding Surprise
Honey Badger Picks Fight With Elephant, Gets Hilariously Booted Away
Tiny Soccer Rivals Choose Hugs Over Competition
